Pharmaceuticals news continually updated from thousands of sources around the net.
3 hrs ago | GuruFocus.com
Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.
5 hrs ago | Drug Researcher
McKesson Corporation, a healthcare services and information technology company, today announced a three-year extension to its pharmaceutical distribution agreement with CVS Caremark.
8 hrs ago | Business Wire
All Board members were reelected and all Board vote recommendations were upheld.
8 hrs ago | The Daily Caller
The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .
8 hrs ago | Forbes.com
Leading up to Teva Pharmaceutical Industries' announcement of its second-quarter earnings on Thursday, July 31, 2014, analysts have become more bullish as expectations have improved over the past month from $1.17 per share to the current projection of earnings of $1.22 per share.
12 hrs ago | Business Wire
"We have a long t... )--Jamba Inc., a leading healthy active lifestyle brand and the leading retailer of freshly squeezed juice today announced that consumers who visit J... )--Tigermed and Frontage complete strategic investment agreement.
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Impax Laboratories, Inc .
North Carolina lawmakers are adding the daughter of billionaire C.D. Spangler to the board overseeing the state's 17-campus public university system.
Shares of Impax Labs sank Tuesday after an FDA inspection uncovered potential problems at a facility where the company will make its experimental Parkinson's disease drug Rytary.
Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.
Impax Laboratories Inc said the U.S. Food and Drug Administration issued "certain observations" after an inspection of the company's manufacturing plant in Taiwan.
's stock had its "buy" rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Monday.
Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.
LNTH, a developer and distributor of imaging agents used in medical diagnostics, plans to raise $125.0 million in its upcoming IPO.
I think we figured out the easy part, which is finding the cure to AIDS. But now we will be faced with another challenge.
Updated: Wed Jul 30, 2014 04:12 pm
Copyright © 2014 Topix LLC